Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 4
1983 3
1984 3
1985 4
1986 2
1987 2
1988 3
1989 2
1990 3
1991 2
1992 2
1993 1
1994 3
1997 2
1998 1
2000 1
2001 2
2002 1
2003 1
2004 2
2005 3
2006 4
2007 3
2008 4
2009 2
2010 4
2011 2
2012 1
2013 8
2014 5
2015 4
2016 6
2017 9
2018 8
2019 3
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 27918545

102 results
Results by year
Filters applied: . Clear all
Page 1
Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer.
Shen G, Cui W, Zhang H, Zhou F, Huang W, Liu Q, Yang Y, Li S, Bowman GR, Sadler JE, Gross ML, Li W. Shen G, et al. Nat Struct Mol Biol. 2017 Jan;24(1):69-76. doi: 10.1038/nsmb.3333. Epub 2016 Dec 5. Nat Struct Mol Biol. 2017. PMID: 27918545 Free PMC article.
Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
Czogalla KJ, Biswas A, Höning K, Hornung V, Liphardt K, Watzka M, Oldenburg J. Czogalla KJ, et al. Nat Struct Mol Biol. 2017 Jan;24(1):77-85. doi: 10.1038/nsmb.3338. Epub 2016 Dec 12. Nat Struct Mol Biol. 2017. PMID: 27941861
Stabilization of warfarin-binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition.
Shen G, Li S, Cui W, Liu S, Liu Q, Yang Y, Gross M, Li W. Shen G, et al. J Thromb Haemost. 2018 Jun;16(6):1164-1175. doi: 10.1111/jth.14127. Epub 2018 May 20. J Thromb Haemost. 2018. PMID: 29665197 Free PMC article.
Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition.
Wu S, Chen X, Jin DY, Stafford DW, Pedersen LG, Tie JK. Wu S, et al. Blood. 2018 Aug 9;132(6):647-657. doi: 10.1182/blood-2018-01-830901. Epub 2018 May 9. Blood. 2018. PMID: 29743176 Free PMC article.
Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
Rost S, Fregin A, Hünerberg M, Bevans CG, Müller CR, Oldenburg J. Rost S, et al. Thromb Haemost. 2005 Oct;94(4):780-6. doi: 10.1160/TH05-02-0082. Thromb Haemost. 2005. PMID: 16270630
Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.
Rishavy MA, Usubalieva A, Hallgren KW, Berkner KL. Rishavy MA, et al. J Biol Chem. 2011 Mar 4;286(9):7267-78. doi: 10.1074/jbc.M110.172213. Epub 2010 Oct 26. J Biol Chem. 2011. PMID: 20978134 Free PMC article.
Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
Fasco MJ, Principe LM, Walsh WA, Friedman PA. Fasco MJ, et al. Biochemistry. 1983 Nov 22;22(24):5655-60. doi: 10.1021/bi00293a031. Biochemistry. 1983. PMID: 6652076
102 results
Jump to page
Feedback